Who invested in Scribe Therapeutics

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 4 months ago

Funding summaryUpdated 26 Oct 2026

$33Mraised across 2 rounds since 2026, from 2 sources

$25MGrant$7.5MRound

Latest round: Round, $7.5MJul 2026
Biggest round: $25MGrant · Jun 2026
Investors: 6

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2027

$25MGrant$7.5MRound

First round: Grant, $25M
Biggest round: $25M

The rounds

Jul 2026
Round$7.5M1 new4 returning
Source recorded
Jun 2026
Grant$25M5 new
Source recorded

Founders and team

From the SEC filings it signed: 1 on the team.

Benjamin OakesExecutive Officer, Directori

On the board, as filediBehzad AghazadehCarl GordonVijay Pande

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Grant2026Round2026

Andreessen Horowitz

Menlo Ventures

RA Capital Management

Wellington Management

Perceptive Advisors

Sanofi

Everyone who backed them

Andreessen HorowitzVC firm2rounds

Menlo VenturesVC firm2rounds

RA Capital ManagementPrivate equity2rounds

Wellington ManagementVC firm2rounds

Perceptive AdvisorsAsset manager1round

SanofiInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Scribe Therapeutics

Who invested in Scribe Therapeutics?

Scribe Therapeutics's investors include Andreessen Horowitz, Menlo Ventures, RA Capital Management, Wellington Management and Perceptive Advisors, and 1 more on record.